+Search query
-Structure paper
Title | The ALS drug riluzole binds to the C-terminal domain of SARS-CoV-2 nucleocapsid protein and has antiviral activity. |
---|---|
Journal, issue, pages | Structure, Vol. 33, Page 39-, Year 2025 |
Publish date | Apr 23, 2024 (structure data deposition date) |
![]() | Marquez-Monino, M.A. / Santiveri, C.M. / de Leon, P. / Camero, S. / Campos-Olivas, R. / Jimenez, M.A. / Saiz, M. / Gonzalez, B. / Perez-Canadillas, J.M. |
![]() | ![]() ![]() |
Methods | X-ray diffraction |
Resolution | 1.3 - 1.57 Å |
Structure data | ![]() PDB-9f2g: ![]() PDB-9f2h: ![]() PDB-9f2i: |
Chemicals | ![]() ChemComp-GOL: ![]() ChemComp-SO4: ![]() ChemComp-HOH: ![]() ChemComp-657: ![]() ChemComp-EDO: ![]() PDB-1h88: |
Source |
|
![]() | VIRAL PROTEIN / CTD / SARS-CoV-2 nucleocapsid / COVID-19 / riluzole / benzothiazols |